Clinical Trial Update: Chronic Myelogenous Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemic Study [Phase 1]

View source ↗

Summary

Phase 1 trial conducted by Bristol-Myers Squibb in chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia has completed. Res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia
• Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Leukemia | Phase 1 | Status: COMPLETED | Results posted: 2011-04-19